Search

Building sustainable global partnerships – the BFIRST perspective on future-proofing global plastic surgery

The British Foundation for International Surgery and Training (BFIRST) marks their 10-year anniversary this year as an organisation. As the international outreach arm of the British Association of Plastic, Reconstructive & Aesthetic Surgeons (BAPRAS), BFIRST focuses on supporting surgeons in...

Enhancing safety in upper face injections: Anatomical considerations for precision and efficacy

The upper face, including forehead and temples, is often overlooked in non-surgical cosmetic procedures with dermal fillers. While horizontal forehead or glabella lines may be a common complaint amongst patients, seldom do they attend with concerns of loss of volume...

In conversation with Miriam Martinez Callejas: an insight into compounding

In this conversation Miriam Martinez Callejas, a pharmacist and founder of Roseway Labs, chats to PMFA Editor, Andrew Burd, about the intricacies of compounding pharmaceuticals and how it can support both practitioners and patients. Miriam Martinez Callejas, Superintendent Pharmacist and...

Extracutaneous Merkel cell carcinoma or metastatic Merkel cell carcinoma with an occult primary?

Merkel cell carcinoma (MCC) is a rare and aggressive malignancy arising from dermal neuroendocrine cells, first described by Toker in 1972 [1]. It is predominately seen in the head and neck region of older, white males and risk factors include...

Stratifying preoperative risk in revision augmentation: the six Cs

Breast augmentation is the most frequently performed cosmetic surgical procedure in the UK [1], and with an increasing number of providers, plastic surgeons are managing revisions without information pertaining to the original procedure. Anticipating the features of successive generations of...

Dermoscopy: an update and personal view

With skin cancer now at epidemic levels, early diagnosis is essential. Specialist Stephen Hayes advocates the use of dermoscopy as a triage tool and explains how to interpret the data. Melanoma skin cancer is now the UK’s fifth most common...